UniProt | Protein Name |
---|---|
P37287 |
|
A0A2K4ZA02 |
|
GO Term | Evidence Code | PMID |
---|---|---|
GPI anchor biosynthetic process | ||
preassembly of GPI anchor in ER membrane | ||
cellular response to leukemia inhibitory factor |
GO Term | Evidence Code | PMID |
---|---|---|
phosphatidylinositol N-acetylglucosaminyltransferase activity | ||
UDP-glycosyltransferase activity | ||
protein binding |
DO ID | Disease Name | Source |
---|---|---|
DOID:2226 | myeloproliferative neoplasm | |
DOID:224 | transient cerebral ischemia | |
DOID:2451 | protein S deficiency | |
DOID:2452 | thrombophilia | |
DOID:2481 | obsolete infantile epileptic encephalopathy | |
DOID:2602 | chondroma | |
DOID:2914 | immune system disease | |
DOID:308 | early myoclonic encephalopathy | |
DOID:3086 | gingival overgrowth | |
DOID:3535 | Unverricht-Lundborg syndrome |
HPO ID | HPO Term |
---|---|
HP:0002639 | Budd-Chiari syndrome |
HP:0002650 | Scoliosis |
HP:0002714 | Downturned corners of mouth |
HP:0002878 | Respiratory failure |
HP:0002987 | Elbow flexion contracture |
HP:0003076 | Glycosuria |
HP:0003121 | Limb joint contracture |
HP:0003138 | Increased blood urea nitrogen |
HP:0003155 | Elevated circulating alkaline phosphatase concentration |
HP:0003202 | Skeletal muscle atrophy |
Disease ID | Disease Name |
---|---|
ORPHA:293181 |
|
OMIM:300868 |
|
OMIM:301072 |
|
OMIM:300818 |
|
ORPHA:447 |
|
ORPHA:3451 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
115161209 | SALTR14788 | ||
115533000 | GADMO30644 | ||
101175518 | ORYLA09410 | ||
115588546 | SPAAU28089 | ||
108707921 | Xenbase:XB-GENE-6485976 | ||
100158632 | Xenbase:XB-GENE-996765 | ||
101951663 | CHRPI17570 | ||
113437365 | PSETE08655 | ||
100541649 | MELGA01427 | ||
103815915 | SERCA09564 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024